Citryll B.V.
- Address
- Rk Gebouw, Kloosterstraat 9
Sponsor Overview
Specializations
Inflammatory Mediated Immune Diseases
Citryll B.V. focuses on inflammatory mediated immune diseases with studies aimed at understanding how its investigational program behaves in immune-driven conditions. This area reflects interest in immunology and the treatment of chronic inflammatory disorders.
- Immune-mediated inflammation
- Inflammatory disease activity
- Translational imaging
The sponsor’s research activity in this area includes work spanning multiple countries and collaborating sites, supporting clinical evaluation in broad immune-inflammatory settings.
Hidradenitis Suppurativa
Another key area of interest is hidradenitis suppurativa, a chronic inflammatory skin disease marked by recurrent lesions and persistent disease burden. The sponsor is studying therapeutic effects in patients with moderate to severe disease.
- Chronic skin inflammation
- Disease burden in hidradenitis suppurativa
- Clinical response in dermatologic inflammation
This therapeutic focus places dermatology and immune-mediated skin disorders at the center of the company’s clinical research portfolio.
Rheumatoid Arthritis
Citryll B.V. is also active in rheumatoid arthritis, with research centered on patients with moderately active disease. This area highlights interest in autoimmune joint disease and persistent synovial inflammation.
- Autoimmune arthritis
- Joint inflammation
- Rheumatology
The sponsor’s work in this field aligns with clinical investigation of therapies intended for chronic musculoskeletal inflammation and disease control.
Diagnostic and Imaging-Oriented Clinical Research
One part of the sponsor’s research landscape involves PET-based imaging and the evaluation of radiolabeled investigational compounds in immune-mediated conditions. This indicates therapeutic interest in both treatment assessment and biological distribution within inflammatory disease settings.
- Positron emission tomography
- Radiolabeled compounds
- Target engagement in inflammatory disease
These activities connect molecular imaging with the clinical study of autoimmune and inflammatory disorders.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Cityview: PET-Based Imaging to Evaluate the Distribution of Radiolabeled CIT-013 in Patients with Inflammatory Mediated Immune Disease |  The Netherlands | Recruiting |
| Evaluation of CIT-013 Efficacy in Moderate to Severe Hidradenitis Suppurativa: A Phase 2a Double-Blind, Randomized, Placebo-Controlled Trial |  Germany Poland Spain The Netherlands | Recruiting |
| Phase 1 Trial of CIT-013 in Immune-Mediated Inflammatory Diseases | The Netherlands | Recruiting |
| Phase IIa Double-Blind, Randomized, Placebo-Controlled Study of CIT-013 on Disease Activity in Moderately Active Rheumatoid Arthritis Patients |  Belgium Germany Poland Spain The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 44 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases3 trials322 other sponsors
- 2.Skin and Connective Tissue Diseases1 trial247 other sponsors
Partnered Research Centres
44 centres- Address
- Ul. Zgierska 249, 91-495 Lodz
- Address
- De Boelelaan 1117, 1081 HV Amsterdam
- Address
- Ul. Na Zaspe 3, 80-546 Gdansk
- Address
- Ul. Henryka Sienkiewicza 23, 30-033 Krakow
- Address
- Ul. Ul. Sliczna 13, 50-566 Wroclaw
- Address
- Ul. Stoleczna 7/200, 15-879 Bialystok
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Citryll B.V..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.